• 1
    Williams JG, Wong WD, Rothenberger DA, Goldberg SM. Recurrence of Crohn's disease after resection. Br J Surg 1991; 78: 10.
  • 2
    Yamamoto T, Keighley MR. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg 2000; 87: 398404.
  • 3
    Cottone M, Orlando A, Viscido A, Calabrese E, Camma C, Casa A. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease. Aliment Pharmacol Ther 2003; 17 (Suppl. 2): 3842.
  • 4
    Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterol 1990; 98: 11238.
  • 5
    Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterol 1994; 106: 6438.
  • 6
    Travis S, Stange EF, Lemann M, et al. European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006; 55 (Suppl. 1): i1635.
  • 7
    Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterol 1990; 99: 95663.
  • 8
    Rutgeerts PJ, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence of: a randomized double blind placebo controlled trial. Gastroenterol 2005; 128: 85661.
  • 9
    Viscido A, Corrao G, Taddei G, Caprilli R. Crohn's disease activity index is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Ital J Gastroenterol Hepatol 1999; 31: 2749.
  • 10
    McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterol 1995; 109: 40413.
  • 11
    Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterol 1995; 108: 3459.
  • 12
    Florent C, Cortot A, Quandale P, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Eur J Gastroenterol Hepatol 1996; 8: 22933.
  • 13
    Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994; 8: 3543.
  • 14
    Sutherland LR, Martin F, Bailey RJ, et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterol 1997; 112: 106977.
  • 15
    Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterol 2000; 118: 26473.
  • 16
    Campieri M, Rizzello F, Venturi A, et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of postoperative recurrence of Crohn's disease: a randomized study vs mesalamine. Gastroenterol 2000; 118: 4179.
  • 17
    Hanauer SB, Korelitz BI, Rutgeerts P, et al. Post-operative maintenance of Crohn's disease remission with mercaptopurine, and MP to 6-MP, mesalamine or placebo: a 2 year trial. Gastroenterol 2004; 127: 7239.
  • 18
    Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterol 2004; 127: 7307.
  • 19
    Cammà C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterol 1997; 113: 146573.
  • 20
    Cottone M, Cammà C. Mesalamine and relapse prevention in Crohn's disease. Gastroenterol 2000; 118: 597.
  • 21
    Cammà C, Viscido A, Latella G, Caprilli R, Cottone M. Mesalamine in the prevention of clinical and endoscopic post-operative recurrence of Crohn's disease: a meta-analysis. Dig Liver Dis 2002; 34: A86.
  • 22
    Caprilli R, Cottone M, Tonelli F, et al. Two mesalazine regimens in the prevention of the postoperative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 2003; 17: 51723.
  • 23
    Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterol 1995; 108: 161721.
  • 24
    Korelitz B, Hanauer S, Rutgeerts P, Present D, Peppercorn M. Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: a 2 year multicenter trial. Gastroenterol 1998; 114: A1011.
  • 25
    Sandborn WJ, Feagan BG. The efficacy of azathioprine and mercaptopurine, and MP to 6-MP for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain. Gastroenterol 2004; 127: 9903.
  • 26
    Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO. Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database Syst. Rev. 2003; 4: CD000301.
  • 27
    Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterol 1999; 116: 294300.
  • 28
    Ewe K, Bottger T, Buhr HJ, Ecker KW, Otto HF. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999; 11: 27782.
  • 29
    Papi C, Luchetti R, Gili L, Montanti S, Koch M, Capurso L. Budesonide in the treatment of Crohn's disease: a meta-analysis. Aliment Pharmacol Ther 2000; 14: 141928.
  • 30
    Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002; 51: 4059.
  • 31
    Marteau P, Lémann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double-blind, placebo-controlled GETAID trial. Gut 2006; 55: 8427.
  • 32
    Van Gossum A, Dewit O, Geboes K, et al. A randomized placebo-controlled clinical trial of probiotics (L. johnsonii La1) on early endoscopic recurrence of Crohn's disease (CD) after ileocaecal resection. Gastroenterol 2005; 128: A17.
  • 33
    Colombel JF, Rutgeerts P, Malchow H, et al. (Tenovil) in the prevention of post-operative recurrence of Crohn's disease. Gut 10 2001; 426.
  • 34
    Belluzzi A, Campieri M, Belloli C, et al. A new enteric-coated preparation of Ω-3 fatty acids for preventing post-surgical recurrence in Crohn's disease. Gastroenterol 1997; 112: A930.